149 related articles for article (PubMed ID: 17891582)
1. Preparation of budesonide-poly (ethylene oxide) solid dispersions using supercritical fluid technology.
Liu H; Zhou LL; Wei LL; Hong-Guo ; Nie SF; Yang XG; Tang R; Pan WS
Drug Dev Ind Pharm; 2007 Sep; 33(9):959-66. PubMed ID: 17891582
[TBL] [Abstract][Full Text] [Related]
2. [Preparation of budesonide-poly (ethylene oxide) solid dispersions using supercritical carbon dioxide and in vitro evaluation].
Liu H; Pan WS; Zhou LL; Zhang ZH
Yao Xue Xue Bao; 2007 Feb; 42(2):206-10. PubMed ID: 17518053
[TBL] [Abstract][Full Text] [Related]
3. Preparation of budesonide- and indomethacin-hydroxypropyl-beta-cyclodextrin (HPBCD) complexes using a single-step, organic-solvent-free supercritical fluid process.
Bandi N; Wei W; Roberts CB; Kotra LP; Kompella UB
Eur J Pharm Sci; 2004 Oct; 23(2):159-68. PubMed ID: 15451004
[TBL] [Abstract][Full Text] [Related]
4. Selection of the suitable polymer for supercritical fluid assisted preparation of carvedilol solid dispersions.
Djuris J; Milovanovic S; Medarevic D; Dobricic V; Dapčević A; Ibric S
Int J Pharm; 2019 Jan; 554():190-200. PubMed ID: 30414899
[TBL] [Abstract][Full Text] [Related]
5. Processing of carbamazepine-PEG 4000 solid dispersions with supercritical carbon dioxide: preparation, characterisation, and in vitro dissolution.
Moneghini M; Kikic I; Voinovich D; Perissutti B; Filipović-Grcić J
Int J Pharm; 2001 Jul; 222(1):129-38. PubMed ID: 11404039
[TBL] [Abstract][Full Text] [Related]
6. Effect of the solid-dispersion method on the solubility and crystalline property of tacrolimus.
Joe JH; Lee WM; Park YJ; Joe KH; Oh DH; Seo YG; Woo JS; Yong CS; Choi HG
Int J Pharm; 2010 Aug; 395(1-2):161-6. PubMed ID: 20580799
[TBL] [Abstract][Full Text] [Related]
7. A novel strategy to design sustained-release poorly water-soluble drug mesoporous silica microparticles based on supercritical fluid technique.
Li-Hong W; Xin C; Hui X; Li-Li Z; Jing H; Mei-Juan Z; Jie L; Yi L; Jin-Wen L; Wei Z; Gang C
Int J Pharm; 2013 Sep; 454(1):135-42. PubMed ID: 23871738
[TBL] [Abstract][Full Text] [Related]
8. Preparation and characterization of gliclazide-polyethylene glycol 4000 solid dispersions.
Patil MP; Gaikwad NJ
Acta Pharm; 2009 Mar; 59(1):57-65. PubMed ID: 19304558
[TBL] [Abstract][Full Text] [Related]
9. Comparative physicochemical characterization of phospholipids complex of puerarin formulated by conventional and supercritical methods.
Li Y; Yang DJ; Chen SL; Chen SB; Chan AS
Pharm Res; 2008 Mar; 25(3):563-77. PubMed ID: 17828444
[TBL] [Abstract][Full Text] [Related]
10. Development of prednisone:polyethylene glycol 6000 fast-release tablets from solid dispersions: solid-state characterization, dissolution behavior, and formulation parameters.
Leonardi D; Barrera MG; Lamas MC; Salomón CJ
AAPS PharmSciTech; 2007 Dec; 8(4):E108. PubMed ID: 18181529
[TBL] [Abstract][Full Text] [Related]
11. Preparation of budesonide/gamma-cyclodextrin complexes in supercritical fluids with a novel SEDS method.
Toropainen T; Velaga S; Heikkilä T; Matilainen L; Jarho P; Carlfors J; Lehto VP; Järvinen T; Järvinen K
J Pharm Sci; 2006 Oct; 95(10):2235-45. PubMed ID: 16883551
[TBL] [Abstract][Full Text] [Related]
12. Physicochemical characterization of solid dispersions of carbamazepine formulated by supercritical carbon dioxide and conventional solvent evaporation method.
Sethia S; Squillante E
J Pharm Sci; 2002 Sep; 91(9):1948-57. PubMed ID: 12210042
[TBL] [Abstract][Full Text] [Related]
13. Understanding the performance of melt-extruded poly(ethylene oxide)-bicalutamide solid dispersions: characterisation of microstructural properties using thermal, spectroscopic and drug release methods.
Abu-Diak OA; Jones DS; Andrews GP
J Pharm Sci; 2012 Jan; 101(1):200-13. PubMed ID: 21905037
[TBL] [Abstract][Full Text] [Related]
14. Cefuroxime axetil solid dispersion with polyglycolized glycerides for improved stability and bioavailability.
Dhumal RS; Biradar SV; Aher S; Paradkar AR
J Pharm Pharmacol; 2009 Jun; 61(6):743-51. PubMed ID: 19505364
[TBL] [Abstract][Full Text] [Related]
15. Preparation, characterization and tableting of cilnidipine solid dispersions.
Hu L; Song W; Niu F; Jiao K; Jia Z
Pak J Pharm Sci; 2013 May; 26(3):629-36. PubMed ID: 23625441
[TBL] [Abstract][Full Text] [Related]
16. Solid dispersion of carbamazepine in PVP K30 by conventional solvent evaporation and supercritical methods.
Sethia S; Squillante E
Int J Pharm; 2004 Mar; 272(1-2):1-10. PubMed ID: 15019063
[TBL] [Abstract][Full Text] [Related]
17. A Comparative Solubility Enhancement Study of Cefixime Trihydrate Using Different Dispersion Techniques.
Obaidat RM; Khanfar M; Ghanma R
AAPS PharmSciTech; 2019 May; 20(5):194. PubMed ID: 31119496
[TBL] [Abstract][Full Text] [Related]
18. Physicochemical characterisation, drug polymer dissolution and in vitro evaluation of phenacetin and phenylbutazone solid dispersions with polyethylene glycol 8000.
Khan S; Batchelor H; Hanson P; Perrie Y; Mohammed AR
J Pharm Sci; 2011 Oct; 100(10):4281-94. PubMed ID: 21560130
[TBL] [Abstract][Full Text] [Related]
19. Improvement of the dissolution rate of artemisinin by means of supercritical fluid technology and solid dispersions.
Van Nijlen T; Brennan K; Van den Mooter G; Blaton N; Kinget R; Augustijns P
Int J Pharm; 2003 Mar; 254(2):173-81. PubMed ID: 12623193
[TBL] [Abstract][Full Text] [Related]
20. Enhanced solubility of piperine using hydrophilic carrier-based potent solid dispersion systems.
Thenmozhi K; Yoo YJ
Drug Dev Ind Pharm; 2017 Sep; 43(9):1501-1509. PubMed ID: 28425323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
